Want to see HK:2171 full AI Analyst Report?
Total Valuation
CARsgen Therapeutics Holdings Ltd. has a market cap or net worth of HK$7.80B. The enterprise value is HK$6.33K.
Market CapHK$7.80B
Enterprise ValueHK$6.33K
Share Statistics
CARsgen Therapeutics Holdings Ltd. has 594,229,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding594,229,550
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CARsgen Therapeutics Holdings Ltd.’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -9.36%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-9.36%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee347.13K
Profits Per Employee-284.27K
Employee Count362
Asset Turnover0.10
Inventory Turnover6.40
Valuation Ratios
The current PE Ratio of CARsgen Therapeutics Holdings Ltd. is ―. CARsgen Therapeutics Holdings Ltd.’s PEG ratio is 0.85.
PE Ratio―
PS Ratio58.60
PB Ratio9.40
Price to Fair Value9.40
Price to FCF-30.30
Price to Operating Cash Flow-133.37
PEG Ratio0.85
Income Statement
In the last 12 months, CARsgen Therapeutics Holdings Ltd. had revenue of 125.66M and earned -97.86M in profits. Earnings per share was -0.18.
Revenue125.66M
Gross Profit79.95M
Operating Income-104.21M
Pretax Income-102.91M
Net Income-97.86M
EBITDA-203.91M
Earnings Per Share (EPS)-0.18
Cash Flow
In the last 12 months, operating cash flow was -47.45M and capital expenditures 47.45M, giving a free cash flow of -53.67M billion.
Operating Cash Flow-47.45M
Free Cash Flow-53.67M
Free Cash Flow per Share-0.09
Dividends & Yields
CARsgen Therapeutics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change-41.76%
50-Day Moving Average14.43
200-Day Moving Average16.37
Relative Strength Index (RSI)44.64
Average Volume (3m)2.61M
Important Dates
CARsgen Therapeutics Holdings Ltd. upcoming earnings date is Mar 23, 2027, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateMar 23, 2027
Ex-Dividend Date―
Financial Position
CARsgen Therapeutics Holdings Ltd. as a current ratio of 5.73, with Debt / Equity ratio of 6.59%
Current Ratio5.73
Quick Ratio5.70
Debt to Market Cap<0.01
Net Debt to EBITDA5.21
Interest Coverage Ratio-15.11
Taxes
In the past 12 months, CARsgen Therapeutics Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CARsgen Therapeutics Holdings Ltd. EV to EBITDA ratio is -30.90, with an EV/FCF ratio of -25.93.
EV to Sales50.14
EV to EBITDA-30.90
EV to Free Cash Flow-25.93
EV to Operating Cash Flow-27.58
Balance Sheet
CARsgen Therapeutics Holdings Ltd. has HK$1.40B in cash and marketable securities with HK$71.98M in debt, giving a net cash position of HK$1.33B billion.
Cash & Marketable SecuritiesHK$1.40B
Total DebtHK$71.98M
Net CashHK$1.33B
Net Cash Per ShareHK$2.23
Tangible Book Value Per ShareHK$1.41
Margins
Gross margin is 67.78%, with operating margin of -82.93%, and net profit margin of -77.88%.
Gross Margin67.78%
Operating Margin-82.93%
Pretax Margin-81.89%
Net Profit Margin-77.88%
EBITDA Margin-162.27%
EBIT Margin-181.36%
Analyst Forecast
The average price target for CARsgen Therapeutics Holdings Ltd. is HK$19.76, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$19.76
Price Target Upside33.78% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast68.12%
EPS Growth Forecast81.84%